{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:49Z","timestamp":1787026309171,"version":"build-2736575974"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extensively drug-resistant tuberculosis (XDR-TB) is a global health threat, being expensive and difficult to treat, with high mortality rates. The Western Cape Province (WCP), South Africa, has a particularly high burden of XDR-TB (&amp;gt;800 cases in the past ten years). Drug resistance genotypes and transmission present substantial regional variability. Thus, a better understanding of genetic diversity, clustering and the factors related to transmission can aid in prioritising resources to effectively target high-risk populations and regions that are disproportionately affected. We describe genetic diversity, drug resistance profiles and identify potential factors associated with the spread of XDR-TB strains collected in the WCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 729 XDR-TB samples (one per patient), identified through routine diagnosis spanning 2010 to 2019, from six healthcare districts (HCDs) in the WCP. Genomic DNA from cultured isolates was sequenced using the Illumina platform. Sequences were analysed for strain type, drug resistance mutations, and genomic clustering using the TBProfiler and MTBseq pipelines. We conducted logistic regression analysis to identify potential factors associated with genomic traits related to the spread of XDR-TB strains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 729 XDR-TB strains, sublineage 2.2.2 (Atypical Beijing: n=378, 58.79%) strains were predominant, followed by Sublineage 2.2.1 (Typical Beijing: n=260, 40.43%). Atypical Beijing strains were more likely to cluster than Typical Beijing strains. Most of the clusters were small, with a few large and very large clusters, and the strains within very large clusters (primarily Atypical Beijing) were more likely to be found within Cape Town Metropole, Cape Winelands and Garden Route HCDs. Certain Atypical Beijing strains were found resistant to new and repurposed drugs recently introduced in the WHO treatment guidelines and clustered, indicating potential transmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Near-untreatable Atypical Beijing strains are prevalent in the WCP. Hence, hotspot areas for clustering in Cape Town Metropole, Cape Winelands and Garden Route HCDs should be prioritised for targeted intervention to prevent ongoing XDR-TB transmission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1638577","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:46Z","timestamp":1756964026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Population structure and emergence of resistance to new and repurposed drugs in XDR-TB: insights from a 10-year genomic study in the Western Cape, South Africa review"],"prefix":"10.3389","volume":"15","author":[{"given":"Justice Tresor","family":"Ngom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Loubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizna","family":"Maasdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Ghebrekristos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarishna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffel J.","family":"Opperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Klopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Mark","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7196\/SAMJ.2021.v111i11.16147","article-title":"Increase in linezolid resistance in staphylococci in the private sector in Western Cape Province, South Africa","volume":"111","author":"Bamford","year":"2021","journal-title":"SAMJ: South Afr. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-020-00793-8","article-title":"MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era","volume":"12","author":"Beckert","year":"2020","journal-title":"Genome Med."},{"key":"B3","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2013worldwide, 2000-2004","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1128\/JCM.05832-11","article-title":"Population structure of multi- and extensively drug-resistant mycobacterium tuberculosis strains in South Africa","volume":"50","author":"Chihota","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12879-020-05031-5","article-title":"Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review","volume":"20","author":"Chisompola","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/ncomms5812","article-title":"A robust SNP barcode for typing Mycobacterium tuberculosis complex strains","volume":"5","author":"Coll","year":"2014","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41588-017-0029-0","article-title":"Genome-wide analysis of multi- and extensively drug-resistant","volume":"50","author":"Coll","year":"2018","journal-title":"Nat. Gene."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.drup.2024.101156","article-title":"Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs","volume":"77","author":"Conkle-Gutierrez","year":"2024","journal-title":"Drug Resistance Updates"},{"key":"B9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7196\/SAMJ.7263","article-title":"Clinical access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis","volume":"104","author":"Conradie","year":"2014","journal-title":"S Afr Med. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1016\/S2666-5247(23)00172-6","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study","volume":"4","author":"Derendinger","year":"2023","journal-title":"Lancet Microbe"},{"key":"B11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cmi.2016.10.008","article-title":"Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"23","author":"Dheda","year":"2017","journal-title":"Clin. Microbiol. Infection"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ng.2656","article-title":"Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug resistant tuberculosis","volume":"45","author":"Ford","year":"2013","journal-title":"Nat. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"Gagneux","year":"2006","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02102-2021","article-title":"In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient","volume":"59","author":"Ghodousi","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/NEJMc2404644","article-title":"Transmission as a key driver of resistance to the new tuberculosis drugs","volume":"392","author":"Goig","year":"2025","journal-title":"New Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-019-1487-2","article-title":"A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic","volume":"18","author":"Klopper","year":"2020","journal-title":"BMC Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3201\/\/EID1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5895","article-title":"MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates","volume":"6","author":"Kohl","year":"2018","journal-title":"PeerJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e00782","DOI":"10.1128\/AAC.00782-20","article-title":"HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis","volume":"64","author":"Loiseau","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12879-017-2881-z","article-title":"Genetic diversity and distribution of Mycobacterium tuberculosis genotypes in Limpopo, South Africa","volume":"17","author":"Maguga-Phasha","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B23","unstructured":"Linezolid fact sheet\n          \n          \n          \n          2014"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00888","DOI":"10.1128\/AAC.00888-17","article-title":"Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance","volume":"61","author":"Metcalfe","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/antibiotics12010166","article-title":"First and second-line anti-tuberculosis drug-resistance patterns in pulmonary tuberculosis patients in Zambia","volume":"12","author":"Monde","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B26","unstructured":"Introduction of new drugs and drug regimens for the management of drug-resistant TB in SA\n          \n          \n          \n          2015"},{"key":"B27","unstructured":"Policy-framework-on-decentralised-management-of-mdr-tb-may-2019\n          \n          \n          \n          2020"},{"key":"B28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3201\/eid2703.204364","article-title":"Clusters of drug-resistant mycobacterium tuberculosis detected by whole-genome sequence analysis of nationwide sample, Thailand, 2014\u20132017","volume":"27","author":"Nonghanphithak","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000815","article-title":"Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa","volume":"8","author":"Oostvogels","year":"2022","journal-title":"Microbial. Genomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1186\/s12879-022-07861-x","article-title":"Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis","volume":"22","author":"Pai","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00900-17","article-title":"In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug-resistant tuberculosis in Beijing, China","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e04531","DOI":"10.1128\/spectrum.04531-22","article-title":"Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India","volume":"11","author":"Rao","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1186\/s12889-023-17234-x","article-title":"Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South Africa","volume":"23","author":"Said","year":"2023","journal-title":"BMC Public Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1128\/JCM.00358-12","article-title":"Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant mycobacterium tuberculosis isolates from the northern region of South Africa","volume":"50","author":"Said","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040050","article-title":"XDR-TB in South Africa: no time for denial or complacency","volume":"4","author":"Singh","year":"2007","journal-title":"PloS Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.05905-11","article-title":"Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing","volume":"56","author":"Streicher","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.meegid.2011.07.019","article-title":"Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa","volume":"12","author":"Streicher","year":"2012","journal-title":"Infection Genet. Evol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1128\/JCM.01414-15","article-title":"Molecular epidemiological interpretation of the epidemic of extensively drug-resistant tuberculosis in South Africa","volume":"53","author":"Streicher","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/ng.3704","article-title":"Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages","volume":"48","author":"Stucki","year":"2016","journal-title":"Nat. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1038\/s41598-022-14581-4","article-title":"Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa","volume":"12","author":"Sy","year":"2022","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002283","article-title":"Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid","volume":"3","author":"Timm","year":"2023","journal-title":"PloS Global Public Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1038\/s41467-021-27616-7","article-title":"Genomic signatures of pre-resistance in Mycobacterium tuberculosis","volume":"12","author":"Torres Ortiz","year":"2021","journal-title":"Nat. Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/jcm.29.11.2578-2586.1991","article-title":"Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis","volume":"29","author":"van Soolingen","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jinf.2021.02.004","article-title":"Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey","volume":"82","author":"Wang","year":"2021","journal-title":"J. Infect."},{"key":"B46","unstructured":"western_cape_strategic_plan_2019-2024.2020"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011675","article-title":"HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa","volume":"20","author":"Windels","year":"2024","journal-title":"PloS Pathog."},{"key":"B48","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance\n          \n          \n          \n          2021"},{"key":"B49","unstructured":"Consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update\n          \n          \n          36630546\n          \n          2022"},{"key":"B50","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance\n          \n          \n          \n          2023"},{"key":"B51","unstructured":"World Health Organization Global Tuberculosis Report 2023"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e00239","DOI":"10.1128\/AAC.00239-17","article-title":"Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis","volume":"61","author":"Xu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13756-021-00995-8","article-title":"Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition","volume":"10","author":"Yao","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/QAI.0000000000001833","article-title":"Effect of antiretroviral therapy on treatment outcomes in a prospective study of extensively drug-resistant tuberculosis (XDR-TB) HIV coinfection treatment in kwaZulu-natal, South Africa","volume":"79","author":"Yuengling","year":"2018","journal-title":"JAIDS J. Acquired Immune Deficiency Syndromes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40001-021-00502-0","article-title":"Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China","volume":"26","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1638577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:56Z","timestamp":1756964036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1638577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":55,"alternative-id":["10.3389\/fcimb.2025.1638577"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1638577","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1638577"}}